Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020 Jul 21, 2020 4:01pm EDT
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia Jun 29, 2020 7:01am EDT
Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association Jun 12, 2020 7:00am EDT
Aptose to Present Early CG-806 Clinical Findings at the 25th Congress of the European Hematology Association May 14, 2020 9:00am EDT
Aptose to Present at 2020 RBC Capital Markets Global Healthcare Virtual Conference May 07, 2020 7:30am EDT
